Metformin and Injection site warmth - a phase IV clinical study of FDA data
We study 429,842 people who have side effects when taking Metformin. Injection site warmth is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Humira and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Metformin and have Injection site warmth. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
429,842 people reported to have side effects when taking Metformin.
Among them, 277 people (0.06%) have Injection site warmth.
What is Metformin?
Metformin has active ingredients of metformin hydrochloride. It is used in diabetes. Currently, eHealthMe is studying from 440,945 Metformin users.
What is Injection site warmth?
Injection site warmth is found to be associated with 1,066 drugs and 685 conditions by eHealthMe. Currently, we are studying 19,646 people who have Injection site warmth.
Number of Metformin and Injection site warmth reports submitted per year:
Time on Metformin when people have Injection site warmth *:
Gender of people who have Injection site warmth when taking Metformin*:
Age of people who have Injection site warmth when taking Metformin *:
Common drugs people take besides Metformin *:
Common side effects people have besides Injection site warmth *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metformin and have Injection site warmth?Check whether Injection site warmth is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .
Metformin side effects by duration, gender and age:
- Metformin side effects (440,945 reports)
Injection site warmth treatments and more:
- Injection site warmth (19,646 reports)
Common drugs associated with Injection site warmth:
- Enbrel: 10,782 reports
- Humira: 2,623 reports
- Methotrexate: 1,579 reports
- Prednisone: 570 reports
- Taltz: 397 reports
- Folic acid: 393 reports
- Makena: 304 reports
- Synthroid: 296 reports
- Metformin: 277 reports
- Vitamin d: 244 reports
All the drugs that are associated with Injection site warmth:
- Injection site warmth (1,066 drugs)
Common conditions associated with Injection site warmth:
- Rheumatoid arthritis: 6,942 reports
- Psoriasis: 2,455 reports
- Ankylosing spondylitis: 913 reports
- Multiple sclerosis: 746 reports
- Crohn's disease: 648 reports
All the conditions that are associated with Injection site warmth:
- Injection site warmth (685 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metformin hydrochloride (the active ingredients of Metformin) and Metformin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lenalidomide and Infusion Site Mass - 23 seconds ago
- Humalog and Protein Urine - 23 seconds ago
- Valsartan and Depo-Testosterone drug interaction - 25 seconds ago
- Victoza and Cilostazol drug interaction - 45 seconds ago
- Eliquis and Lung Infiltration - a minute ago
- Avastin and Peritonitis - a minute ago
- Humira and Peritonitis - a minute ago
- Claritin and Zantac 75 drug interaction - a minute ago
- Zocor and Gastrointestinal Ulcer - a minute ago
- Methotrexate and Peritonitis - a minute ago